Active substance
Thiamine
- SFDA 1
- US FDA 23
- Health Canada 2
- US price lines 1
- NHS prices 3
- WHO EML 1
- Safety 5
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| THIAVIT 100MG TAB | 100 mg | Tablet · Oral use | 1 Blister | SAR 8.20 | Generic · OTC | Gulf Pharmaceutical Industries (Julphar) | Valid |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | FRESENIUS KABI USA | Prescription | 20 Jun 1972 |
| THIAMINE HYDROCHLORIDE | 100MG/ML; 200MG/ML | injectable · injection | DR REDDYS | Prescription | 26 Feb 1974 |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | WEST-WARD PHARMS INT | Prescription | 24 Jun 1975 |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | MYLAN INSTITUTIONAL | Prescription | 25 Jun 2012 |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | SAGENT PHARMS INC | Prescription | 1 Dec 2017 |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | EUGIA PHARMA | Prescription | 20 Apr 2022 |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | CAPLIN | Prescription | 6 Mar 2023 |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | ONESOURCE SPECIALTY | Prescription | 29 Oct 2024 |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | ASPIRO | Prescription | 6 Nov 2024 |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | GLAND | Prescription | 24 Feb 2025 |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | MANKIND PHARMA | Prescription | 31 Jul 2026 |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | HONG KONG | Prescription | 25 Sep 2026 |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | PARKE DAVIS | Discontinued | 6 Dec 1972 |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | BEL MAR | Discontinued | 4 Feb 1974 |
| THIAMINE HYDROCHLORIDE | 200MG/ML | injectable · injection | BEL MAR | Discontinued | 26 Feb 1974 |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | WYETH AYERST | Discontinued | 27 Mar 1974 |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | DELL LABS | Discontinued | 6 Aug 1974 |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | HOSPIRA | Discontinued | 3 May 1996 |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | ABRAXIS PHARM | Discontinued | |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | LUITPOLD | Discontinued | |
| BETALIN S | 100MG/ML | injectable · injection | LILLY | Discontinued | |
| THIAMINE HYDROCHLORIDE | 100MG/ML; 200MG/ML | injectable · injection | WATSON LABS | Discontinued | |
| THIAMINE HYDROCHLORIDE | 100MG/ML | injectable · injection | EPIC PHARMA LLC | Discontinued |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| THIAMIJECT INJECTION - LIQ IM IV 100MG/ML | 02193221 | 100 MG / ML | LIQUID · INTRAMUSCULAR; INTRAVENOUS | OMEGA LABORATORIES LIMITED |
| VITAMIN B1 | 00816078 | 100 MG / ML | SOLUTION · INTRAMUSCULAR; INTRAVENOUS | SANDOZ CANADA INCORPORATED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | THIAMINE 200 MG/2 ML VIAL | $2.24683 | per ML | 23 Sep 2026 |
| NHS Drug Tariff | Thiamine 100mg tablets | £2.79 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Thiamine 250mg/5ml solution for injection ampoules | £16.23 | 6 ampoule | 1 Oct 2026 |
| NHS Drug Tariff | Thiamine 50mg tablets | £2.15 | 100 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 27. Vitamins and minerals · core
Vitamin B1 deficiency
Parenteral > General injections > IV: 50 mg per mL in ampoule or vial (hydrochloride) (EMLc) | Oral > Solid > tablet: 50 mg (hydrochloride)
Safety signals and safety-related labeling changes
- US FDA 6 Nov 2024 INFUVITE ADULT — safety-related labeling change
Labeling sections changed: Use in Specific Populations - US FDA 6 Nov 2024 INFUVITE PEDIATRIC — safety-related labeling change
Labeling sections changed: Use in Specific Populations - US FDA 16 Dec 2020 M.V.I. ADULT — safety-related labeling change
Labeling sections changed: Contraindications; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 9 Nov 2017 M.V.I. ADULT (PHARMACY BULK PACKAGE) — safety-related labeling change
Labeling sections changed: Contraindications; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 9 Nov 2017 M.V.I.-12 — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Combinations containing Thiamine
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.